Zhu Mei
- Topics
- MicroRNA in disease regulation (5 papers)Epigenetics and DNA Methylation (4 papers)Cancer, Hypoxia, and Metabolism (3 papers)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Zhu Mei
21 papers receiving 843 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 609
- Cancer Research 331
- Oncology 206
- Immunology 94
- Epidemiology 89
Countries citing papers authored by Zhu Mei
This map shows the geographic impact of Zhu Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhu Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhu Mei more than expected).
Fields of papers citing papers by Zhu Mei
This network shows the impact of papers produced by Zhu Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhu Mei. The network helps show where Zhu Mei may publish in the future.
Co-authorship network of co-authors of Zhu Mei
This figure shows the co-authorship network connecting the top 25 collaborators of Zhu Mei. A scholar is included among the top collaborators of Zhu Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhu Mei. Zhu Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 10 | |
| 4 | 23 | |
| 5 | 31 | |
| 6 | 42 | |
| 7 | 34 | |
| 8 | 3 | |
| 9 | 75 | |
| 10 | ROR1 promotes the proliferation of endometrial cancer cells. | 3 |
| 11 | Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44. | 33 |
| 12 | 8 | |
| 13 | 182 | |
| 14 | 15 | |
| 15 | 19 | |
| 16 | 3 | |
| 17 | 25 | |
| 18 | Combination of thalidomide and transcatheter arterial chemoembolization for advanced hepatocellular carcinoma | 1 |
| 19 | 210 | |
| 20 | [Influence of dietary selenium level on immune function of rats with esophageal tumors induced by methylbenzylnitrosamine (NMBzA)]. | 2 |
About Zhu Mei
Zhu Mei is a scholar working on Cancer Research, Critical Care and Intensive Care Medicine and Oncology, having authored 22 papers that have together received 850 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (331 citations), Molecular Biology (609 citations) and Oncology (206 citations). Zhu Mei has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Mingjie Jiang, Dian-na Gu, Ling Tian, Xinjiao Gao, Changjiang Jin, Longping Wen, Yu Xue, Jian Ren, Xuebiao Yao and Andrew Shaw. Their work appears in journals such as Cancer Cell, Frontiers in Immunology and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.